Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
The Honest Company
HNST
$586M
| $7.19M | ﹤0.01% |
2,012,937
+4,829
| +0.2% | +$18.1K |
|
2052
Terex
TEX
$7.74B
| $7.18M | ﹤0.01% |
135,739
-17,376
| -11% | -$960K |
|
2053
Darling Ingredients
DAR
$9.44B
| $7.16M | ﹤0.01% |
192,747
-8,940
| -4% | -$337K |
|
2054
Mirum Pharmaceuticals
MIRM
$6.14B
| $7.15M | ﹤0.01% |
183,344
+168,037
| +1,098% | +$6.7M |
|
2055
Park National Corp
PRK
$3.67B
| $7.15M | ﹤0.01% |
42,541
+1,184
| +3% | +$196K |
|
2056
Twist Bioscience
TWST
$7.25B
| $7.14M | ﹤0.01% |
158,120
-14,560
| -8% | -$693K |
|
2057
DXP Enterprises
DXPE
$2.98B
| $7.13M | ﹤0.01% |
133,703
+4,587
| +4% | +$230K |
|
2058
Kosmos Energy
KOS
$1.48B
| $7.13M | ﹤0.01% |
1,770,170
+46,118
| +3% | +$225K |
|
2059
NeoGenomics
NEO
$2.13B
| $7.13M | ﹤0.01% |
483,235
-5,692
| -1% | -$89.1K |
|
2060
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.06B
| $7.12M | ﹤0.01% |
816,459
+28,424
| +4% | +$239K |
|
2061
Fidelity MSCI Industrials Index ETF
FIDU
$2.39B
| $7.12M | ﹤0.01% |
98,591
-23,756
| -19% | -$1.62M |
|
2062
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$693M
| $7.12M | ﹤0.01% |
114,061
-24,018
| -17% | -$1.4M |
|
2063
BlackRock Multi-Sector Income Trust
BIT
$702M
| $7.11M | ﹤0.01% |
468,087
-164,267
| -26% | -$2.43M |
|
2064
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.53B
| $7.06M | ﹤0.01% |
334,041
+29,156
| +10% | +$608K |
|
|
UHT
2065
Universal Health Realty Income Trust
UHT
$594M
| $7.06M | ﹤0.01% |
154,310
+1,390
| +0.9% | +$59.8K |
|
2066
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.5B
| $7.04M | ﹤0.01% |
304,970
+34,774
| +13% | +$788K |
|
|
CTLT
2067
DELISTED
CATALENT, INC.
CTLT
| $7.04M | ﹤0.01% |
116,188
-7,694
| -6% | -$455K |
|
2068
Ceco Environmental
CECO
$4.14B
| $7.03M | ﹤0.01% |
249,458
-19,380
| -7% | -$545K |
|
2069
Bloomin' Brands
BLMN
$937M
| $7.02M | ﹤0.01% |
424,915
-1,910
| -0.4% | -$33.9K |
|
2070
Brown-Forman Class B
BF.B
$13.1B
| $7.02M | ﹤0.01% |
142,579
+64,347
| +82% | +$2.89M |
|
2071
JD.com
JD
$44.5B
| $7.02M | ﹤0.01% |
175,496
+79,718
| +83% | +$2.19M |
|
2072
Invesco BuyBack Achievers ETF
PKW
$1.76B
| $7.02M | ﹤0.01% |
61,287
+592
| +1% | +$64.1K |
|
2073
Amphastar Pharmaceuticals
AMPH
$916M
| $7.02M | ﹤0.01% |
144,598
+20,685
| +17% | +$908K |
|
2074
Cullinan Oncology
CGEM
$1.14B
| $6.99M | ﹤0.01% |
417,508
+13,630
| +3% | +$242K |
|
2075
WisdomTree US High Dividend Fund
DHS
$1.58B
| $6.98M | ﹤0.01% |
74,413
-261
| -0.3% | -$23.5K |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.